Implantable biosensor

Details Implantable biosensor Implantable biosensor

2004-09-24

2008-10-07

Nasser, Jr., Robert L. (Department: 3735)

Surgery

Diagnostic testing

Measuring or detecting nonradioactive constituent of body...

C600S347000, C600S365000

Reexamination Certificate

active

07433727

ABSTRACT:
The invention consists of a sensor with multiple indicating (sensing) electrodes covered with a selectively permeable membrane for monitoring fluid concentrations in a biological environment. The indicating electrodes respond to changes in certain analytes, such as glucose, through an enzyme-mediated reaction. The currents generated from the enzyme-mediated reactions are transmitted through radio signals to an external receiver where the information is processed and recorded. Through the use of various biomaterials and biochemicals associated with the sensor, the monitoring accuracy is improved and the overall viability is prolonged. The process of foreign body fibrosis (formation of a scar capsule around the implanted sensor) eventually limits the functional life of the device. We teach methods of delivery of certain biochemicals that can increase the functional life of the sensor by inhibiting the formation of the foreign body capsule or by stimulating the growth of capillaries into the capsule.

REFERENCES:
patent: 5165407 (1992-11-01), Wilson et al.
patent: 5711861 (1998-01-01), Ward et al.
patent: 5741330 (1998-04-01), Brauker et al.
patent: 6001067 (1999-12-01), Shults et al.
patent: 6121009 (2000-09-01), Heller et al.
patent: 6122535 (2000-09-01), Kaestle et al.
patent: 6212416 (2001-04-01), Ward et al.
patent: 6233471 (2001-05-01), Berner et al.
patent: 6442413 (2002-08-01), Silver
patent: 6466810 (2002-10-01), Ward et al.
patent: 6477395 (2002-11-01), Schulman et al.
patent: 6484046 (2002-11-01), Say et al.
patent: 6512939 (2003-01-01), Colvin et al.
patent: 6514718 (2003-02-01), Heller et al.
patent: 2001/0020137 (2001-09-01), Granger
patent: 2002/0120186 (2002-08-01), Keimel
patent: 2005/0043598 (2005-02-01), Goode et al.
Hu, W. J., J. W. Eaton, et al. (2001). “Molecular basis of biomaterial-mediated foreign body reactions.”Blood98(4): 1231-8.
Katou, F., H. Ohtnai, et al. (1998). “Procollagen-positive fibroblasts predominantly express fibrogenic growth factors and their receptors in human encapsulation process against foreign body.”J Pathol186(2): 201-8.
Khouw, I. M., P. B. van Wachem, et al. (1999). “TGF-beta and bFGF affect the differentiation of proliferating porcine fibroblasts into myofibroblasts in vitro.”Biomaterials20(19): 1815-22.
O'Connor, S. M., S. J. Patuto, et al. (1997). “Fibrinogen-dependent adherence of macrophages to surfaces coated with poly(ethylene oxide)/poly(propylene oxide) triblock copolymers.”Ann N Y Acad Sci831: 138-44.
Roberts, A. B., E. Piek, et al. (2001). “Is Smad3 a major player in signal transduction pathways leading to fibrogenesis?”Chest120(1 Suppl): 43S-47S.
Updike, S. J., M. C. Shults, et al. (2000). “A subcutaneous glucose with improved longevity, dynamic range, and stability of calibration.”Diabetes Care23: 208-214.
Wolf, G., F. N. Ziyadeh, et al. (1995). “Angiotensin II-stimulated expression of transforming growth factor beta in renal proximal tubular cells: attenuation after stable transfection with the c-mas oncogen.”Kidney Int48(6): 1818-27.

Affiliated with

Also associated with

Rating

Implantable biosensor does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Implantable biosensor, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Implantable biosensor will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-4015974